Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes.
The in vitro interactions between vaccinia virus (VV) and monocyte-derived human dendritic cells (DC) have been studied to gain a better understanding of the mechanisms involved in the induction of an immune response by VV. This work showed that VV binds to DC less efficiently than to HeLa cells (HeLa). Capping of viral antigens on the DC surface and electron microscopic examinations suggested that VV enters into DC mainly by endocytosis instead of fusion as for HeLa. Early viral-encoded proteins were expressed in DC but late viral proteins and viral DNA synthesis did not occur. Nevertheless, when successfully infected, DC expressed a similar amount of a foreign, viral-encoded protein, as HeLa, if the early component of the p7.5 promoter was used. VV infection did not lead to DC maturation as determined by following the level of several cell surface markers associated with maturation, but an inhibition of the expression of the costimulatory molecule CD80 was noticed. The proliferation of allogeneic peripheral blood lymphocytes (PBL) was stimulated by VV-infected DC or inhibited depending on the particular donor lymphocytes employed. PBL from VV-vaccinated individuals with good memory responses to VV antigens proliferated in the presence of infected autologous DC. PBL from individuals with poor memory responses to VV and one unvaccinated individual also proliferated, albeit to a lower level, in the presence of infected autologous DC. These results suggest that VV-infected DC could both stimulate memory cells and prime naive cells in vitro.
Drillien
R
R
Equipe Propre INSERM 99-08, Etablissement de Transfusion Sanguine de Strasbourg. robert.drillien@etss.u-strasbg.fr
Spehner
D
D
Bohbot
A
A
Hanau
D
D
D002454:Cell Differentiation / Q000276:immunology; D002460:Cell Line; D004261:DNA Replication / Q000502:physiology; D004279:DNA, Viral / Q000096:biosynthesis; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000821:virology*; D004705:Endocytosis; D006367:HeLa Cells; D006801:Humans; D017874:Immediate-Early Proteins / Q000096:biosynthesis; D007399:Interphase / Q000276:immunology; D008213:Lymphocyte Activation; D009000:Monocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000821:virology*; D010641:Phenotype; D014407:Tumor Cells, Cultured; D014616:Vaccinia virus / Q000235:genetics* / Q000276:immunology* / Q000502:physiology; D014779:Virus Replication / Q000502:physiology
D004279:DNA, Viral; D017874:Immediate-Early Proteins